gms | German Medical Science

G-I-N Conference 2012

Guidelines International Network

22.08 - 25.08.2012, Berlin

Factors influencing the number of days required for cancer guideline development projects from initiation to completion at Cancer Care Ontario’s Program in Evidence-Based Care (PEBC)

Meeting Abstract

Suche in Medline nach

  • S. McNair - Cancer Care Ontario, Toronto, Canada; McMaster University, Hamilton, ON, Canada
  • H. Messersmith - Cancer Care Ontario, Toronto, Canada; McMaster University, Hamilton, ON, Canada
  • M. Brouwers - Cancer Care Ontario, Toronto, Canada; McMaster University, Hamilton, ON, Canada

Guidelines International Network. G-I-N Conference 2012. Berlin, 22.-25.08.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocP101

DOI: 10.3205/12gin213, URN: urn:nbn:de:0183-12gin2134

Veröffentlicht: 10. Juli 2012

© 2012 McNair et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Background: The development of rigorous, evidence-based guidelines requires significant time by many people. PEBC staff methodologists work with our clinical partners to optimize efficiencies in the process. Nonetheless, length of time continues to be a challenge. To better manage the expectations of sponsors and participants in our guideline projects, we want to be better able to make accurate predictions of guideline development time.

Objectives: To identify factors that influence the time required to complete the development of a guideline. To identify factors that can be used to estimate the duration of future projects. To identify factors that can be modified to shorten development time.

Methods: Participants in PEBC guideline projects (staff, clinical partners, sponsors) were asked to identify factors that affect guideline development time. Data from the PEBC projects database was analyzed to explore the relationship between identified factors and development time.

Results: Factors to be investigated include: Scope of guideline, Attributes of the evidence, Attributes of guideline development group, Programmatic factors.

Discussion: The PEBC has a well developed process and protocol for developing cancer guidelines. Findings from this work will be applicable for other guideline projects and to non-cancer topics and will identify priorities for future methodological initiatives aimed to shorten development time.

Implications for guideline developers/users: Taking into account the factors that affect guideline development time may help guideline developers to better manage resources and expectations while maintaining the quality and rigour of guidelines.